VLTO Veralto

Q2 2025 10-Q

Filed: Apr 30, 2025Period ending Apr 4, 2025

Health Care

Instruments For Meas & Testing of Electricity & Elec SignalsSEC EDGAR

Veralto (VLTO) 10-Q quarterly report for Q2 2025, filed with SEC EDGAR on Apr 30, 2025 for the fiscal period ending Apr 4, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q2 2025 10-Q

Risk Factors

• New trade restriction risk triggered by U.S. government imposing significant tariffs since January 2025 on imports from China and other countries
• Most materially updated risk: impact of retaliatory tariffs and political tensions on global economic conditions and financial market stability

+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$1.4B

Net Income

$222M

Net Margin

16.2%

Source: XBRL data from Veralto Q2 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other Veralto Quarterly Reports

Q4 2025 10-Q

Q3 2025 10-Q

Get deeper insights on Veralto

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.